OLYMPUS On-Demand Library
Add to Watch

PLASMA – THE SAFE CHOICE

Comparable Clinical Outcome and Increased Safety Profi le

The PLASMA (TURis) system offers an equivalent efficacy to monopolar TURP8,15 that includes maximum flow rate (Qmax), resection weight/radicality, PVR (Post-Void Residual), and IPSS (International Prostate Symptom Score)/IIEF-5 (International Index of Erectile Function). Clinical outcomes are followed for up to 36 months, which is the longest among the surgical options.10

Compared to monopolar technology, the PLASMA (TURis) system has a more favorable perioperative safety profile, especially regarding TUR syndrome occurrence, frequency of blood transfusions, and the clot retention rate.18

* The risk of fluid overload remains.

The strong safety profile of the PLASMA (TURis) system also results in a reduced average length of hospital stay, shorter catheterization times, and fewer postoperative readmissions.18